Alpha Tau Medical (DRTS) Accumulated Expenses (2021 - 2025)
Alpha Tau Medical's (DRTS) quarterly Accumulated Expenses came in at $122000.0 in Q4 2025, down 95.33% year-on-year from $2.6 million in Q4 2024, and down 95.33% quarter-over-quarter from $2.6 million in Q4 2024.
Alpha Tau Medical (DRTS) Accumulated Expenses (2021 - 2025) Analysis & Trends
Alpha Tau Medical has disclosed Accumulated Expenses across 5 years of filings, most recently posting $122000.0 for Q4 2025.
- Accumulated Expenses for Q4 2025 came in at $122000.0, down 95.33% year-over-year; the trailing twelve-month figure through Dec 2025 was $122000.0 (down 95.33% YoY), and the FY2025 annual result was $122000.0, down 95.33% from the prior year.
- Accumulated Expenses came in at $122000.0 for Q4 2025 at Alpha Tau Medical, down from $2.6 million in the prior quarter.
- In the past five years, Accumulated Expenses ranged from a high of $2.6 million in Q4 2024 to a low of $8000.0 in Q4 2022.
- The 5-year median for Accumulated Expenses is $122000.0 (2025), against an average of $1.0 million.
- Across the five-year window, Accumulated Expenses slumped 99.66% in 2022 and soared 2193.86% in 2024, its largest moves.
- Alpha Tau Medical's Accumulated Expenses stood at $2.4 million in 2021, then plunged by 99.66% to $8000.0 in 2022, then jumped by 1325.0% to $114000.0 in 2023, then jumped by 2193.86% to $2.6 million in 2024, then sank by 95.33% to $122000.0 in 2025.
- The last three Accumulated Expenses figures came in at $122000.0 (Q4 2025), $2.6 million (Q4 2024), and $114000.0 (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | Alpha Tau Medical | 2,384.20 | -76.42 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 122,000.00 |
| Dec 31, 2024 | 2.62 Mn |
| Dec 31, 2023 | 114,000.00 |
| Dec 31, 2022 | 8,000.00 |
| Dec 31, 2021 | 2.37 Mn |